Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4i5x | FLF | Aldo-keto reductase family 1 member B10 | 1.1.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4i5x | FLF | Aldo-keto reductase family 1 member B10 | 1.1.1 | 1.000 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.510 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.500 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.493 | |
5dsg | 0HK | Muscarinic acetylcholine receptor M4 | / | 0.488 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.484 | |
1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.483 | |
3af1 | GDP | Pantothenate kinase | 2.7.1.33 | 0.483 | |
1ype | UIP | Prothrombin | 3.4.21.5 | 0.482 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.479 | |
2b8j | ADN | Class B acid phosphatase | 3.1.3.2 | 0.478 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | 1.2.4.1 | 0.477 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 1.2.4.1 | 0.477 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.476 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.475 | |
2xuj | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.475 | |
4jq3 | ZOM | Aldo-keto reductase family 1 member C2 | / | 0.474 | |
4u16 | 3C0 | Muscarinic acetylcholine receptor M3 | / | 0.474 | |
1mab | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.473 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.472 | |
4bfs | ZVS | Pantothenate kinase | 2.7.1.33 | 0.472 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.472 | |
1nqv | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.471 | |
2ipi | AKY | Aclacinomycin-N/aclacinomycin-A oxidase | / | 0.471 | |
3zv7 | NHG | Acetylcholinesterase | 3.1.1.7 | 0.471 | |
1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.470 | |
2bd0 | NAP | Sepiapterin reductase | / | 0.470 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.470 | |
3mjr | AC2 | Deoxycytidine kinase | 2.7.1.74 | 0.470 | |
3std | MQ0 | Scytalone dehydratase | 4.2.1.94 | 0.470 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.470 | |
5cxv | 0HK | Muscarinic acetylcholine receptor M1 | / | 0.470 | |
1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.469 | |
2zf0 | 51U | Prothrombin | 3.4.21.5 | 0.469 | |
2zs8 | ADP | Pantothenate kinase | 2.7.1.33 | 0.469 | |
4a80 | 2AN | Major pollen allergen Bet v 1-A | / | 0.469 | |
4phl | PIL | Phosphodiesterase | / | 0.469 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.468 | |
2cbq | TH2 | Neocarzinostatin | / | 0.468 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.468 | |
3bjc | WAN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.467 | |
3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.467 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.467 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.466 | |
1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.466 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.466 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.466 | |
4u95 | MIY | Multidrug efflux pump subunit AcrB | / | 0.466 | |
1lke | DOG | Bilin-binding protein | / | 0.465 | |
1t7o | 152 | Carnitine O-acetyltransferase | 2.3.1.7 | 0.465 | |
2dv0 | ZST | Aldose reductase | 1.1.1.21 | 0.465 | |
2zfq | 45U | Prothrombin | 3.4.21.5 | 0.465 | |
3g1r | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.465 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.465 | |
2geu | COK | Pantothenate kinase | 2.7.1.33 | 0.464 | |
1s36 | CEI | Obelin | / | 0.463 | |
1w4l | GL8 | Acetylcholinesterase | 3.1.1.7 | 0.463 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.463 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.463 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.463 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
1aqu | EST | Estrogen sulfotransferase, testis isoform | 2.8.2.4 | 0.462 | |
3exf | TPP | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | 1.2.4.1 | 0.462 | |
3exf | TPP | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 1.2.4.1 | 0.462 | |
3zc3 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.462 | |
2xuh | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
3af3 | GCP | Pantothenate kinase | 2.7.1.33 | 0.461 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.461 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.461 | |
3bv7 | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.460 | |
4jtr | IZP | Aldo-keto reductase family 1 member C2 | / | 0.460 | |
1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
2qw8 | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.459 | |
4fam | 0SZ | Aldo-keto reductase family 1 member C3 | / | 0.459 | |
4mrm | 2BY | Gamma-aminobutyric acid type B receptor subunit 1 | / | 0.459 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
2zi2 | 24U | Prothrombin | 3.4.21.5 | 0.458 | |
3qen | 5BT | Deoxycytidine kinase | 2.7.1.74 | 0.458 | |
4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.458 | |
1vkg | CRI | Histone deacetylase 8 | 3.5.1.98 | 0.457 | |
2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
3af4 | GCP | Pantothenate kinase | 2.7.1.33 | 0.457 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.457 | |
4oex | 5EO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.457 | |
1d3d | BZT | Prothrombin | 3.4.21.5 | 0.456 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.456 | |
2e0n | SAH | Precorrin-2 C20-methyltransferase | / | 0.456 | |
2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
3ce0 | P34 | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.456 | |
3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
3qwc | 98P | Prothrombin | 3.4.21.5 | 0.456 | |
4kn0 | MTX | Folate receptor beta | / | 0.456 | |
1ex7 | 5GP | Guanylate kinase | 2.7.4.8 | 0.455 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
3fow | IMH | Purine nucleoside phosphorylase | / | 0.455 | |
4daj | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.455 | |
1d3p | BT3 | Prothrombin | 3.4.21.5 | 0.454 | |
1gaq | FAD | Ferredoxin | / | 0.454 | |
1z3n | 3NA | Aldose reductase | 1.1.1.21 | 0.454 | |
1zrb | 062 | Prothrombin | 3.4.21.5 | 0.454 | |
3dop | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.454 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
3uzz | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.454 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.454 | |
4fa3 | 0SL | Aldo-keto reductase family 1 member C3 | / | 0.454 | |
4hmn | 16J | Aldo-keto reductase family 1 member C3 | / | 0.454 | |
4i9z | 5BA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.454 | |
4x3u | SVR | Chromobox protein homolog 7 | / | 0.454 | |
1a26 | CNA | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.453 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.453 | |
1w6r | GNT | Acetylcholinesterase | 3.1.1.7 | 0.453 | |
3c1o | NAP | Eugenol synthase | / | 0.453 | |
3ld5 | LDT | Aldose reductase | 1.1.1.21 | 0.453 | |
3wg6 | NDP | NADPH-dependent conjugated polyketone reductase C1 | / | 0.453 | |
1kms | LIH | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.452 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
3c49 | KU8 | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.452 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.452 | |
3zku | HCV | Isopenicillin N synthase | 1.21.3.1 | 0.452 | |
4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.452 | |
4g8c | C6L | Alpha/beta hydrolase fold protein | / | 0.452 | |
1crb | RTL | Retinol-binding protein 1 | / | 0.451 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
2fz9 | ZST | Aldose reductase | 1.1.1.21 | 0.451 | |
2hv5 | ZST | Aldose reductase | 1.1.1.21 | 0.451 | |
3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.451 | |
3caq | NDP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.451 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
3n39 | FMN | Protein NrdI | / | 0.451 | |
4kp6 | 1S1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.451 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.451 | |
4n3l | 2FN | Prothrombin | 3.4.21.5 | 0.451 | |
4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.451 | |
1jwt | BLI | Prothrombin | 3.4.21.5 | 0.450 | |
1lnm | DTX | Bilin-binding protein | / | 0.450 | |
1z5u | CMP | Class B acid phosphatase | / | 0.450 | |
2zhw | 12U | Prothrombin | 3.4.21.5 | 0.450 | |
3fzn | D7K | Benzoylformate decarboxylase | 4.1.1.7 | 0.450 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.450 | |
3vo2 | FAD | Ferredoxin--NADP reductase | / | 0.450 | |
3zj0 | ACO | Putative acetyltransferase OgpAT | / | 0.450 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.450 | |
1fvp | FMA | Non-fluorescent flavoprotein | / | 0.449 | |
1h42 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.449 | |
1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.449 | |
1t40 | ID5 | Aldose reductase | 1.1.1.21 | 0.449 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.449 | |
2zev | IPE | Geranylgeranyl pyrophosphate synthase | / | 0.449 | |
3nu0 | 3TU | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
3ug8 | IMN | Aldo-keto reductase family 1 member C3 | / | 0.449 | |
4zas | TYD | CalS13 | / | 0.449 | |
1efy | BZC | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.448 | |
1t4v | 14A | Prothrombin | 3.4.21.5 | 0.448 | |
1tfz | 869 | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.448 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.448 | |
2hzq | STR | Apolipoprotein D | / | 0.448 | |
2iki | 388 | Aldose reductase | 1.1.1.21 | 0.448 | |
2jj8 | AZZ | Deoxynucleoside kinase | / | 0.448 | |
2pd9 | FID | Aldose reductase | 1.1.1.21 | 0.448 | |
2pzn | 393 | Aldose reductase | 1.1.1.21 | 0.448 | |
2zsb | ADP | Pantothenate kinase | 2.7.1.33 | 0.448 | |
3cot | STR | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.448 | |
3ntr | NAD | Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase | 1.1.1.18 | 0.448 | |
3up3 | XCA | aceDAF-12 | / | 0.448 | |
4j0y | 1H6 | Beta-secretase 1 | 3.4.23.46 | 0.448 | |
4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.448 | |
4mv1 | ADP | Biotin carboxylase | 6.3.4.14 | 0.448 | |
1nzq | 162 | Prothrombin | 3.4.21.5 | 0.447 | |
1qti | GNT | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.447 | |
2fzb | TOL | Aldose reductase | 1.1.1.21 | 0.447 | |
2iqd | LPA | Aldose reductase | 1.1.1.21 | 0.447 | |
2nvc | ITA | Aldose reductase | 1.1.1.21 | 0.447 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
3d73 | NBB | Pheromone-binding protein ASP1 | / | 0.447 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.447 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.447 | |
4ax9 | N5N | Prothrombin | 3.4.21.5 | 0.447 | |
4c77 | N01 | Phenylacetone monooxygenase | 1.14.13.92 | 0.447 | |
4glx | 0XS | DNA ligase | 6.5.1.2 | 0.447 | |
1dx6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
1que | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.446 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.446 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
2i65 | NAD | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 3.2.2.6 | 0.446 | |
2xuk | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
3ghu | LDT | Aldose reductase | 1.1.1.21 | 0.446 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.446 | |
4ajg | F07 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
4j17 | 1HQ | Beta-secretase 1 | 3.4.23.46 | 0.446 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.446 | |
1q6n | P90 | Tyrosine-protein phosphatase non-receptor type 1 | 3.1.3.48 | 0.445 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.445 | |
1w6j | R71 | Lanosterol synthase | 5.4.99.7 | 0.445 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.445 | |
2pdf | ZST | Aldose reductase | 1.1.1.21 | 0.445 | |
2pdu | 393 | Aldose reductase | 1.1.1.21 | 0.445 | |
2psj | CEI | Renilla-luciferin 2-monooxygenase | 1.13.12.5 | 0.445 | |
2xi4 | AFT | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
3aiv | HBO | 4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl glucoside beta-D-glucosidase, chloroplastic | 3.2.1.182 | 0.445 | |
3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.445 | |
3b8x | G4M | Putative pyridoxamine 5-phosphate-dependent dehydrase | / | 0.445 | |
3q9b | B3N | Acetylpolyamine amidohydrolase | / | 0.445 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
4eil | FOL | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
4j7g | TRH | PCZA361.3 | / | 0.445 | |
1mcz | TDP | Benzoylformate decarboxylase | 4.1.1.7 | 0.444 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.444 | |
1pq6 | 965 | Oxysterols receptor LXR-beta | / | 0.444 | |
2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.444 | |
2bdy | UNB | Prothrombin | 3.4.21.5 | 0.444 | |
2h3w | HC5 | Carnitine O-acetyltransferase | 2.3.1.7 | 0.444 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
3dr7 | GPD | GDP-perosamine synthase | / | 0.444 | |
4k9p | TPP | Benzoylformate decarboxylase | 4.1.1.7 | 0.444 | |
4l32 | 1VF | Tankyrase-2 | 2.4.2.30 | 0.444 | |
4xo7 | ASD | Aldo-keto reductase family 1 member C2 | / | 0.444 | |
1ihi | IU5 | Aldo-keto reductase family 1 member C2 | / | 0.443 | |
1mu6 | CDA | Prothrombin | 3.4.21.5 | 0.443 | |
1pax | DHQ | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.443 | |
2xae | ADP | Kinesin-like protein KIF11 | / | 0.443 | |
3fu8 | 3DM | Laccase-1 | 1.10.3.2 | 0.443 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
3p2v | DOY | Aldose reductase | 1.1.1.21 | 0.443 | |
3t0k | DCQ | Sulfide-quinone reductase | / | 0.443 | |
3tfu | PL8 | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 2.6.1.62 | 0.443 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
4jq2 | SUZ | Aldo-keto reductase family 1 member C2 | / | 0.443 | |
4kd7 | 9DR | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
4m6l | 21V | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.442 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.442 | |
3g4l | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
3h7r | NAP | Aldo-keto reductase family 4 member C8 | / | 0.442 | |
3r8h | ZOM | Aldo-keto reductase family 1 member C3 | / | 0.442 | |
4af7 | FAD | Ferredoxin--NADP reductase, leaf isozyme, chloroplastic | 1.18.1.2 | 0.442 | |
4kxj | P34 | Nucleoprotein | / | 0.442 | |
1ah3 | TOL | Aldose reductase | 1.1.1.21 | 0.441 | |
1e66 | HUX | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
1mcz | RMN | Benzoylformate decarboxylase | 4.1.1.7 | 0.441 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.441 | |
1qv0 | CZH | Obelin | / | 0.441 | |
2r6j | NDP | Eugenol synthase 1 | 1.1.1.318 | 0.441 | |
2rc6 | FAD | Ferredoxin--NADP reductase | / | 0.441 | |
2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.441 | |
2xnp | WCX | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.441 | |
2zs9 | ADP | Pantothenate kinase | 2.7.1.33 | 0.441 | |
3eku | CY9 | Actin-5C | / | 0.441 | |
3eq0 | 2TS | Prothrombin | 3.4.21.5 | 0.441 | |
3hf8 | ML0 | Tryptophan 5-hydroxylase 1 | 1.14.16.4 | 0.441 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.441 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.441 | |
4bam | MM9 | Prothrombin | 3.4.21.5 | 0.441 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.441 | |
1gjr | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.440 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.440 | |
1ypg | UIR | Prothrombin | 3.4.21.5 | 0.440 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
2zhf | 49U | Prothrombin | 3.4.21.5 | 0.440 | |
3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
3qkz | NAP | Aldose reductase-related protein 1 | 1.1.1.21 | 0.440 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.440 | |
4jpg | 1OX | Pyruvate kinase PKM | 2.7.1.40 | 0.440 | |
4kq6 | DLZ | 6,7-dimethyl-8-ribityllumazine synthase | / | 0.440 | |
5cmx | 0G6 | Prothrombin | 3.4.21.5 | 0.440 |